Aortic valve surgery in octogenarians: predictive factors for operative and long-term results by Kolh, Philippe et al.
DOI: 10.1016/j.ejcts.2007.01.003 
 2007;31:600-606 Eur J Cardiothorac Surg
Philippe Kolh, Arnaud Kerzmann, Charles Honore, Laetitia Comte and Raymond Limet 
 long-term results
Aortic valve surgery in octogenarians: predictive factors for operative and
This information is current as of April 2, 2007 
 http://ejcts.ctsnetjournals.org/cgi/content/full/31/4/600
located on the World Wide Web at: 
The online version of this article, along with updated information and services, is
Print ISSN: 1010-7940. 
European Association for Cardio-Thoracic Surgery. Published by Elsevier B.V. All rights reserved.
for Cardio-thoracic Surgery and the European Society of Thoracic Surgeons. Copyright © 2007 by 
The European Journal of Cardio-thoracic Surgery is the official Journal of the European Association
 by Philippe Kolh on April 2, 2007 ejcts.ctsnetjournals.orgDownloaded from 
www.elsevier.com/locate/ejcts
European Journal of Cardio-thoracic Surgery 31 (2007) 600—606Aortic valve surgery in octogenarians: predictive factors for operative
and long-term results§
Philippe Kolh a,*, Arnaud Kerzmann a, Charles Honore a, Laetitia Comte b, Raymond Limet a
aCardiothoracic Surgery Department, University Hospital of Lie`ge, Lie`ge, Belgium
bDepartment of Biostatistics, University Hospital of Lie`ge, Lie`ge, Belgium
Received 28 September 2006; received in revised form 26 December 2006; accepted 4 January 2007AbstractObjective: To assess factors influencing operative and long-term outcome in octogenarians undergoing aortic valve surgery (AVR). Methods:
Records of 220 consecutive octogenarians having AVR between 1992 and 2004 were reviewed, and follow-up obtained (99% complete). Of the
group (mean age: 82.8 years; 174 females), 142 patients (65%) were in New York Heart Association (NYHA) class III—IV, 22 (10%) had previous
myocardial infarction, 11 (5%) had previous coronary artery bypass grafting (CABG), and 8 (4%) had percutaneous aortic valvuloplasty. There were
44 urgent procedures (20%), and additional CABG was performed in 58 patients (26%). Results: Operative mortality was 13% (9% for AVR, 24% for
AVR + CABG). Among the 29 patients who died, 14 (48%) were operated on urgently (32% mortality for urgent procedures). Causes of hospital
death were respiratory insufficiency or infection in 16 patients (16/29 = 55%), myocardial infarction in 8 (28%), stroke in 2 (7%), sepsis in 2 (7%),
and renal failure in 1 (3%). Significant postoperative complications were atrial fibrillation in 48 patients (22%), respiratory insufficiency in 46
(21%), permanent atrio-ventricular bloc in 12 (5%), myocardial infarction in 10 (5%), hemodialysis in 4 (2%), and stroke in 4 (2%). Mean hospital and
intensive care unit (ICU) stays were 17.6  5.2 and 6.9  3.4 days, respectively. Multivariate predictors (p < 0.05) of hospital death were urgent
procedure, associated CABG, NYHA class IV, and percutaneous aortic valvuloplasty. Age, associated CABG, and urgent procedure were predictors
of prolonged ICU stay. Mean follow-up was 58.2 months and actuarial 5-year survival was 73.2  6.9%. Age, preoperative myocardial infarction,
urgent procedure, and duration of ICU stay were independent predictors of late death. Among 130 patients alive at follow-up, 91% were angina
free and 81% in class I—II. Conclusions: AVR in octogenarians can be performed with acceptable mortality, although significant morbidity. These
results stress the importance of early operation on elderly patients with aortic valve disease, avoiding urgent procedures. Associated coronary
artery disease is a harbinger of poor operative outcome. Long-term survival and functional recovery are excellent.
# 2007 European Association for Cardio-Thoracic Surgery. Published by Elsevier B.V. All rights reserved.
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The increase in life span of European and American
populations over the past decades has resulted in a significant
increase in the number of people aged more than 80 years.
With this aging of the population and the greater use of
noninvasive diagnostic techniques, particularly echocardio-
graphy with two-dimensional Doppler ultrasonography, the
diagnosis of symptomatic aortic valve disease, particularly
aortic stenosis, is becoming increasingly common [1,2].
Recent reports reveal that cardiac operations for selected
elderly individuals who have otherwise good physical and
mental health can improvemortality,morbidity, and quality of§ Presented at the joint 20th Annual Meeting of the European Association for
Cardio-thoracic Surgery and the 14th Annual Meeting of the European Society
of Thoracic Surgeons, Stockholm, Sweden, September 10—13, 2006.
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ejcts.ctsnetjournals.orDownloaded from life [3—5], but long-term results are incomplete, especially for
valve disease. While previously uncommon, we have observed
in our center, during the last 15 years, a significant increase in
the number of patients aged 80 years and more who are being
referred for aortic valve surgery, and this despite a context of
growing control of health care expenditures, where onemight
think that expensive procedures, such as cardiac operations,
would be limited in elderly patients.
To analyze these issues further, we have reviewed our
early and long-term results in patients aged 80 years and
more who underwent aortic valve replacement (AVR) at our
institution, between January 1992 and December 2004.2. Methods
2.1. Population
Records of all 220 consecutive patients, aged 80 years or
more, who underwent aortic valve replacement betweenurgery. Published by Elsevier B.V. All rights reserved.
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Table 1
Patient clinical characteristics
Variable No. of patients (%)
Men 46 (21)
Women 174 (79)
Age (years) 82.8  2.4
Status — elective 176 (80)
Status — urgent 44 (20)
NYHA — class III 76 (34)
NYHA — class IV 66 (30)
Previous MI 22 (10)





Preoperative atrial fibrillation 30 (14)
Preoperative pacemaker 21 (10)
Renal insufficiency 9 (4)
Previous vascular surgery 14 (6)
Previous CABG 11 (5)
Previous percutaneous aortic valvuloplasty 8 (4)January 1992 and December 2004 were reviewed (retro-
spective study). A total of 40 preoperative, operative, and
postoperative variables were recorded and tested as possible
predictors for operative events and long-term survival1
(Appendix A). Follow-up information was obtained from all
hospital survivors through clinic visits and annual letters, and
was 99% complete. Mean follow-up was 58.2 months, and
cumulative follow-up was 854 patient-years. Between
January and March 2005, all known survivors were questioned
to obtain information regarding general health status,
presence or absence of chest pain, shortness of breath
according to the New York Heart Association (NYHA)
functional class, and quality of life. If subsequent hospita-
lization, death, or other events had occurred, the patient’s
physician or hospital record department was contacted to
document the events and hospitalization.
Significant coronary artery disease was defined as a
reduction of vessel diameter by at least 70% in one view on
coronary angiography. Stenosis to this degree in the left
anterior descending system, circumflex system, or right
coronary system was used for the criterion of single, double,
or triple vessel disease. Urgent operations were defined as
operative procedures performed in patients whose acceler-
ated symptoms prompted urgent hospital admission for
evaluation and who were judged to be too unstable for
discharge before surgery.
Operative mortality was any death occurring within 30
days of the operation or death during the same hospital
admission as the operation. Postoperative course was
followed up in terms of bleeding, cardiac and renal status,
assisted ventilation duration, and neurological events.
Congestive heart failure was determined by the presence
of pulmonary congestion or opacities consistent with edema
on chest roentgenograms. Perioperative myocardial infarc-
tion was defined as either a new Q wave or the elevation of
the myocardial fraction of creatinine kinase in association
with persistent ST segment changes or a new conduction
abnormality. Serum troponin measurement was not routinely
available at the beginning of the series. As our routine
intensive care unit (ICU) stay for patients without early
postoperative complications was 48 h, we defined prolonged
ICU stay as >2 days.
Anesthesiological protocol was mainly the same through-
out this period, extracorporeal circulation was performed
with a membrane oxygenator, and myocardial protection
used cold crystalloid cardioplegia solution added to topical
cooling.
At the time of follow-up, patient activity level was rated
as heavy, defined as running or lifting heavy objects;
moderate, defined as ability to do cleaning; light, defined
as activities of daily living; and bedridden.
2.2. Statistical analysis
Distribution for all relevant variables was expressed either
as percentages or as mean  standard deviation. The effects
of nominal risk factors, such as presence of hypertension, on
early mortality were evaluated univariately with x2 test or1 Postoperative variables were only tested as possible predictors for long-
term survival.
ejcts.ctsnetjournals.orgDownloaded from Fisher’s exact test. The effects of continuous variables, such
as age, were univariately evaluated with Pearson’s correla-
tion test or with Wilcoxon rank sum tests when necessary.
Combinations of risk factors were multivariably evaluated
with multiple logistic regression models, using the stepwise
method (for which input and output p-values were 0.10) to
determine the best predictors. Survivorship to death, for all
patients and for operative survivors only, was estimated with
the Kaplan—Meier method. To assess separately those risk
factors related to late survival as distinct from operative
deaths, we analyzed only operative survivors. Nominal risk
factors for survival and for prolonged hospital stay were
assessed with log-rank tests. Continuous measurable risk
factors, such as age, and combinations of risk factors, both
nominal and continuous, were evaluated with Cox’s propor-
tional hazard models. A p-value <0.05 was considered
statistically significant. All tests were two-sided. The
proportional hazards assumptions were verified by assessing
the parallelism of survival curves for nominal risk factors and
by testing the independence to time for continuous variables.
Moreover, the behavior of the Schoenfeld residuals was
studied. For all continuous variables, we considered the
logarithm of the variable and the polynomial until the third
degree, to keep the form which improved the model at best.
Statistical analysis was performed using the software SAS
(SAS Institute Inc., Cary, NC, USA).3. Results
3.1. Patient population and operative data
The population consisted of 220 consecutive patients
ranging in age from 80 to 94 years who underwent AVR, either
alone or in combination with other procedures. Clinical
characteristics of these patients are listed in Table 1. Most
common presenting symptoms were dyspnea on exertion or
at rest in 180 patients (82%), congestive heart failure in 130NYHA, New York Heart Association; MI, myocardial infarction; COPD, chronic
obstructive pulmonary disease; CABG, coronary artery bypass grafting.
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Table 3
Variables associated with operative mortality and prolonged hospital stay, by
multivariable analysis
Variables p-value OR (95% CI)
Predictive of operative mortality
Urgent procedure 0.003 4.3 (2.3—7.0)
Associated CABG 0.009 3.9 (1.8—5.7)
NYHA functional class 0.01 2.2 (1.2—3.9)
Percutaneous aortic valvuloplasty 0.04 1.7 (0.9—3.6)
Predictive of prolonged hospital staya (>15 days)
Age 0.006 0.9 (0.9—1.0)
Associated CABG 0.009 0.7 (0.6—0.9)
Urgent procedure 0.01 0.4 (0.2—0.8)
OR, odds ratio; CI, confidence interval; CABG, coronary artery bypass grafting;
NYHA, New York Heart Association.
a The model assessed the probability of leaving the hospital, and therefore
a risk ratio of less than 1% is predictive of prolonged hospital stay.patients (59%), angina in 128 patients (58%), and syncopal
episodes in 48 patients (22%).
Assessment of left ventricular (LV) function showed that
26 patients (12%) had poor function, defined as an ejection
function of <40%. Mean ejection fraction was 56.8  12.7%.
Mean aortic valve area and gradient were 0.57  0.16 cm2
and 58.0  21 mmHg, respectively, while mean LV end-
diastolic pressure was 22.9  6.7 mmHg. Fifty-eight patients
(26%) had significant coronary artery disease, while 11
patients (5%) had previous coronary artery bypass grafting
(CABG).
Aortic stenosis was the predominant valvular lesion in 174
patients (79%), followed by combined aortic stenosis and
insufficiency in 40 patients (18%), and aortic insufficiency in
6 patients (3%). Valvular disease involved calcified lesions in
208 patients (94%), bicuspid valve in 26 patients (12%),
myxomatous degeneration in 18 patients (8%), rheumatic
disease in 5 patients (2%), and endocarditis in 4 patients
(2%).
Stented bioprostheses were implanted in 194 patients
(88%), stentless bioprostheses in 17 patients (8%), and
mechanical valves in 9 patients (4%). Average valve size was
21.4 mm. Additional CABG was performed in 58 patients
(26%), respectively for one-vessel disease in 20 (9%), two-
vessel disease in 26 (12%), and three-vessel disease in 12
(5%). Mean cardiopulmonary bypass time was 105.4 
39.8 min, and mean aortic cross-clamp time was
67.3  21.8 min.
3.2. Postoperative complications
Early postoperative complications are listed in Table 2.
Arrhythmias occurred in 53 patients (24%), of whom 48 had
atrial fibrillation or supraventricular tachycardia, and five
had ventricular tachycardia. Among 46 patients (21%)
requiring prolonged (>24 h) mechanical ventilation, 34
(15%) had pneumonia. Four patients (1.8%) developed
cerebrovascular accident, of which one completely recov-
ered before hospital discharge. Eighty-eight patients (40%)
had no postoperative complications.
Length of hospital and ICU stays averaged 17.6  5.2 and
6.9  3.4 days, respectively, while median hospital and ICU
stays were 15 and 5 days, respectively. Ninety patients (40%)
had a prolonged hospital stay (>15 days). Excluding 24
patients who stayed in the hospital for more than 30 days,
average hospital stay was 14.4  4.5 days, and average
intensive care unit stay was 3.8  2.6 days.
Table 2
Operative results
Variable No. of patients (%)
Death 29 (13)
Stroke 4 (2)
Myocardial infarction 10 (4)
Arrhythmias 53 (24)
Permanent atrio-ventricular block 12 (5)
Pneumonia 34 (15)
Prolonged mechanical ventilation (>24 h) 46 (21)
Dialysis 11 (5)
Reexploration for bleeding 9 (4)
Pericardial drainage 7 (3)
Sternal wound reoperation 3 (1)
ejcts.ctsnetjournals.orDownloaded from 3.3. Hospital mortality
Hospital deaths occurred in 29 patients (13%) of which 22
(10%) represent 30-day mortality. Of the 29 patients, 21
(72%) were women and 14 (48%) were operated on urgently.
Fifteen patients (15/162 = 9%) had aortic valve replacement
alone, and 14 (14/58 = 24%) had combined AVR—CABG.
Seventeen patients (17/66 = 26%) were in NYHA class IV.
Six patients (6/8 = 75%) with previous percutaneous aortic
valvuloplasty and one patient (1/11 = 9%) with previous
CABG died. Causes of hospital death were respiratory
insufficiency or infection in 16 patients (16/29 = 55%),
myocardial infarction in 8 (28%), stroke in 2 (7%), sepsis in
2 (7%), and renal failure in 1 (3%).
During the 1992—1998 operative period, 16/102 (16%)
patients died, while 13/118 (11%) patients died during the
1999—2004 operative period (NS).
Independent variables predicting early mortality or
prolonged hospital stay on multivariable logistic regression
analysis are listed in Table 3.
3.4. Late mortality
One hundred and ninety-one patients were discharged
from hospital. A total of 59 patients have died at follow-up,
among which 17 (29%) from cardiac causes, while 2 patients
(1%) were lost to follow-up.Fig. 1. Survival curve of all patients aged 80 years or older undergoing aortic
valve replacement.
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Table 4
Variables associated with long-term survival (operative survivors), by multi-
variable analysis
Variables p-value HR (95% CI)
Preoperative variables
Age <0.0001 1.1 (1.0—1.1)
Previous myocardial infarction 0.005 2.3 (1.3—6.0)
Operative variables
Urgent procedure 0.01 2.0 (1.2—2.3)
Postoperative variables
Duration of ICU stay 0.002 2.7 (1.0—6.9)
HR, hazard ratio; CI, confidence interval; ICU, intensive care unit.Long-term survival for the entire population (including
operative deaths) is depicted in Fig. 1. Survival at 1, 3, and 5
years was 85.5  2.0%, 80.8  2.6%, and 73.2  3.9%,
respectively. When stratified based on urgency of operation,
survival for elective surgery was 88.1  1.9%, 84.3  2.8%,
and 78.1  6.5% at 1, 3, and 5 years, respectively, as
compared with 82.8  6.9%, 76.6  10.8%, and 47.7  16.7%
( p < 0.01) at 1, 3, and 5 years, respectively, for urgent
operations.
Independent predictors of late mortality by multiple Cox-
regression are listed in Table 4. Furthermore, implantation of
a stentless bioprosthesis showed a trend toward better long-
term survival, but without reaching statistical significance
( p = 0.09).
3.5. Quality of life assessment
Three patients, including one with a mechanical valve,
developed thromboembolism complications. Two of those
were peripheral emboli, successfully treated by surgical
embolectomy, and onewas responsible for a cerebro-vascular
accident with mild permanent impairment. We did not
experience other valve-related complications, such as
bleeding events, prosthetic valve endocarditis, structural
failure, or reoperation.
At the time of follow-up, NYHA functional class and
activity level of the 130 alive patients were assessed. The
majority of patients were in NYHA class I (64/130, 49%) or
class II (41/130, 32%), while 118 patients (91%) were angina
free. The majority of patients rated their activity level as
heavy (27/130, 20%) or moderate (70/130, 54%). Among the
130 long-term survivors, 91% believed that having heart
surgery after age 80 years was a good choice, and similarly
88% felt as good as or better than they had preoperatively.4. Discussion
The elderly population continues to expand in western
countries, and acquired heart disease is a leading cause of
death among the elderly. Because aortic valvular disease
remains a common problem in the elderly, increasing number
of elderly patients are presenting for surgical evaluation of
symptomatic valve disease.
The natural prognosis of severe aortic stenosis is ominous:
90% of patients with angina and syncope diedwithin 3 years of
the onset of symptoms and if heart failure was present deathejcts.ctsnetjournals.orgDownloaded from occurred within 2 years [6]. Balloon aortic valvuloplasty has
been proposed as an alternative to operation in the
treatment of aortic valve stenosis [7]. Nevertheless,
published hospital mortality ranged from 3 to 10% [8,9],
and hospital morbidity from 10 to 25%. Furthermore, the
majority of patients had restenosis within 6 months and
survival curves showed 55—75% survival at 1 year [8,9].
4.1. Operative mortality and morbidity
Early reports of AVR in elderly patients showed high
operative mortality rates; however, more recent reports
have shown mortality rates of 2—10% for isolated AVR
[3—5,10,11]. Recently, Chiappini et al. [5] and Collart et al.
[11], respectively, reported a 8.5% and a 8.8% operative
mortality after AVR in octogenarians.
Our hospital mortality for 162 patients who underwent
isolated AVR was 9%, decreasing from 12% in the first half of
the series to 7% in the second half. These results show that
AVR can be performed with an acceptable risk in patients
older than 80 years of age. Significant improvement in
surgical outcome has been ascribed to advances in myocar-
dial protection, anesthesia, and postoperative critical care.
We sought to define risk factors that would be predictors
of early death in this elderly population. Multivariate logistic
regression analysis showed that the only preoperative risk
factors associated with operative mortality were urgent
procedure, associated coronary artery surgery, NYHA func-
tional class, and previous percutaneous valvuloplasty. While
Collart et al. [11] did not report operative mortality to be
higher in surgical urgency, we found urgent procedure to be
the most significant risk factor for operative death.
Poor left ventricular function was also predictive of
hospital death in several studies [4,5,10,11]. Elayada et al.
[10] also found hypertension and concomitant surgical
procedures to be associated with early mortality. Akins
et al. [3] found chronic lung disease, preoperative intra-
aortic balloon, and congestive heart failure to be preopera-
tive predictors of hospital death.
It is important to note that in our experience, previous
aortic valvuloplasty was an independent factor predicting
operative mortality. Our operative mortality for AVR after
failed valvuloplasty was 75% (6/8 patients), which was much
higher than in the series of Otto et al. [9], who reported an
operative mortality of 12% after failed aortic valvuloplasty.
However, it is possible that, in our series, those patients
referred for valvuloplasty were initially felt to be very poor
surgical candidates.
In our series, age itself was not a predictor for operative
mortality. However, age was a predictor for prolonged ICU
stay, as were associated CABG and urgent procedure.
Our postoperative complication rate was somewhat high
(60%), but comparable to the recent series of Collart et al.
[11] who reported a morbidity of 63%. Pulmonary insuffi-
ciency or infection was one of the leading causes of
postoperative morbidity. Our 21% incidence of prolonged
(>24 h) mechanical ventilation was somewhat higher than
the 11% reported by Collart et al. [11], although these
authors did not clearly define prolonged ventilation. In these
elderly patients, we are now having encouraging results with
early extubation (less than 6 h postoperatively) and more by Philippe Kolh on April 2, 2007 
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developed postoperative arrhythmias, 48 had atrial fibrilla-
tion or supraventricular tachycardia that was rapidly treated
with either intravenous antiarrhythmic agents or cardiover-
sion. The incidence of other postoperative complications,
such as stroke, dialysis, myocardial infarction, or reopera-
tion, was comparable with other recent reports [3—5,11]. In
particular, our stroke rate (2%) was low.
4.2. Long-term survival and quality of life
For the entire population, survival at 1, 3, and 5 years was
85.5  2.0%, 80.8  2.6%, and 73.2  3.9%, respectively.
These survival rates are comparable with other studies and
show good long-term survival despite advanced age [4,5,
10—12].
In our study, age, previous myocardial infarction, urgent
procedure, and duration of ICU stay were risk factors
predictive of late mortality, by multivariate analysis. These
results suggest that elderly patients should be referred for
operation as early as possible to prevent urgent operations
or advanced stage disease. Urgent operation also was
predictive of late mortality in other studies [8,13]. Survival
stratified based on urgency of operation clearly emphasizes
that referral of elderly patents before end-stage disease
requiring urgent operations is important for long-term
results.
Of at least equal importance to the elderly as survival is
quality of life. In this study, 91% of long-term survivors
believed in retrospect that having decided to have cardiac
surgery after age 80 years had been a good choice.
Furthermore, at a mean follow-up of 58.5 months post-
operatively, 68% of survivors were still living at home or with
their families. Finally, concerning valve-related complica-
tions, thromboembolic events occurred in four patients, with
permanent disability in only one patient, while no bleeding
events, prosthetic valve endocarditis, structural failure, nor
need for reoperation were observed.
We believe the bioprosthetic valve remains the safest
cardiac valve substitute in the octogenarians. In the earlier
part of the series, we implanted mechanical valves in a few
patients in whom anticoagulant therapy was already
indicated, but now also use bioprosthetic valves in those
patients. An earlier report by Jamieson et al. [14] states that
structural deterioration of tissue valves is limited in the
elderly population. Recently, Suttie et al. [15] reported
excellent long-term results after implantation of aortic
bioprostheses in elderly patients.
Furthermore, the use of stentless valves allows for
implantation of larger prostheses, which in our study has
beneficial effects on long-term survival, however, without
reaching statistical significance on multivariate analysis.
Recently, Ali et al. [16] reported, in a prospective
randomized trial, that both stented and stentless bioprosth-
eses are associated with excellent clinical and hemodynamic
outcomes 1 year after AVR, and that, in patients with
ventricular impairment, stentless valves could allow for
greater improvement of left ventricular function postopera-
tively. It should, however, be emphasized that stentless
bioprostheses are usually more difficult to suture in these
elderly patients with often calcified Valsalva sinus and,ejcts.ctsnetjournals.orDownloaded from therefore, require a longer clamping time than stented
prostheses.
4.3. Combined aortic valve surgery and coronary artery
bypass grafting
Aortic valve replacement combined with coronary artery
bypass grafting resulted in a 24% early and a 10% late
mortality. This is noticeably higher than the 6.3% early
mortality reported by Akins et al. [3]. However, Langanay
et al. [17] recently showed a gradual increase in mortality
according to the number of disease vessels (no significant
lesion 8.2%, single-vessel disease 11.5%, two-vessel 11.1%,
and three-vessel 18.5%) or of associated bypasses (10.1% for
isolated AVR vs 18.8% when multiple bypasses were
associated).
Conventional practice suggests that revascularization
should be performed at the time of aortic valve replacement
if major coronary artery stenosis is present regardless of the
presence or absence of angina [18]. Reports [19] in younger
patient population indicate that myocardial revasculariza-
tion does not increase the operative mortality of valve
replacement, and the functional result may be improved by
relieving the symptoms of angina and providing improved
myocardial protection. This aggressive approach requires
prolonged ischemic time and may not be appropriate in the
octogenarians. We now tend to believe that in octogenarians,
only those with critical (> 80%) coronary lesions or severe
angina should undergo concomitant coronary bypass grafting.
Less than complete revascularization may be an acceptable
alternative in this elderly subset of patients when congestive
heart failure is a primary indication for operation. Other
possible options that we are now contemplating include
preoperative percutaneous coronary interventions or off-
pump bypass grafting.5. Conclusions
In summary, AVR can be performed in patients 80 years old
or older with acceptable mortality, good long-term results,
and good quality of life. Preoperative risk factors associated
with early mortality involve previous percutaneous valvulo-
plasty, associated CABG, and NYHA functional class IV,
whereas age and myocardial infarction were predictors of
late mortality. Urgent procedure was an independent
predictor of both early and late mortality.
We believe octogenarians with aortic valve disease should
not be denied the benefits of surgery if they are reasonably
good surgical candidates, are physiologically and mentally
able to withstand the stress of surgery, and have good
motivation for an improved life style.
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Appendix A. Conference discussion
Dr P. Kappetein (Rotterdam, The Netherlands): If you look at this series
retrospectively are there patients that you nowadays would consider for
percutaneous aortic valve implantation?
Dr Kolh: Well, it would definitely be better to answer this question with a
prospective study, but definitely yes, now that we are seeing these new
techniques and their early results, I am impressed. On Saturday at the Techno-
College, we saw a life case from Leipzig, an 88-year-old lady in whom was
performed a percutaneous aortic valve replacement through the transfemoral
approach, and who had full hemodynamic recovery within minutes. I think that
is definitely something that should be considered, yes.
Dr A. Abdelghany (Cairo, Egypt): As regards the predictive value for
postoperative mortality and late mortality, you ignored the preoperativeejcts.ctsnetjournals.orgDownloaded from status of the patient as regards associated diseases like diabetes, pulmonary
diseases, urinary infection. As regards to your patients, most of them are above
80. So I think some of them had renal infection, had preoperative pulmonary
complications, most of them may be diabetic. This is my first comment.
Dr Kolh: I’m sorry, but I didn’t understand most of your first comment.
Dr Kappetein: Can you please rephrase it a little bit in a short way, your
first question?
Dr Abdelgany: He ignores the preoperative status of the patients as
regards renal function, liver function, pulmonary function.
Dr Kolh: Most of those patients were in fairly good preoperative condition.
In that period of time included in this retrospective study, we probably would
not have operated on an octogenarian patient with extensive liver or kidney
disease. Anyway, all those variables, creatinine level or liver function or
pulmonary function, were included in the multivariate model. Some of those
variables were significant with univariate analysis, which I didn’t show because
of the sake of time, but they were not significant in the multivariate analysis.
You will see a list of all variables included in the model detailed in the
manuscript, if accepted for publication.
Dr Abdelgany: Second is the operative risk factors as regards the degree of
calcification of the aortic valve, atherosclerosis of the aorta, and the size of
the valve you implant.
Dr Kolh: Well, some patients had ascending aorta calcifications. Three
patients required some decalcification of the aorta. As I said, six patients had
surgery on the ascending aorta. And what is your question regarding the valve?
You mean where we implanted it?
Dr Abdelgany: The size of the valve.
Dr Kolh: Mean size was 21.4 mm. So most patients had a 21 mm valve
implanted, some had a 23 mm, remember, most patients were female, and a
few patients had a 19 mm valve.
Dr E. Raanani (Tel Hashomer, Israel): First, you showed a reduction in
mortality and morbidity in the second period. What were the measures, if any,
in order to reduce the mortality or to improve the results in the second period?
And the second question is, a significant number of your patients had
perioperative MI and died from it. And then you raised the question whether
the coronary lesion should be addressed. Did the patients who died from
myocardial infarction have incomplete revascularization or those patients had
coronary bypass and did die?
Dr Kolh: For the first question, that is a retrospective study, so there is
always a lot of bias. I think one of the main points is that we try now to put
those patients on a fast track for extubation and more physical and respiratory
therapy, and also we use short-action hypnotic agents so that they could be
awakened earlier. I think this is one point. The second point is that probably
between 1992 and 2004, some improvement in myocardial protection
occurred.
Now, for your second question, actually I didn’t show that, but we saw that
myocardial infarction (MI) developed more frequently, although not sig-
nificantly, in patients having combined surgery. Among the eight patients who
died from MI, five were in the combined group and three were in the aortic
valve replacement only group, while in the AVR alone group, main cause of
death was respiratory problems. But to answer, most of these patients had
complete revascularization. I am not sure that it is a problem of
revascularization. I think those are actually different patients, patients with
more vascular disease, with coronary and sometimes peripheral artery
disease, as compared with patients with isolated aortic valve stenosis. by Philippe Kolh on April 2, 2007 
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